Back to search

France· FR:63947710

GALANTAMINE ARROW LAB LP 8 mg, gélule à libération prolongée

A galantamine product containing bromhydrate de galantamine, registered in France by ARROW GENERIQUES. The same ATC class is registered in 17 of our 19 countries.

ATC N06DA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGALANTAMINE ARROW LAB LP 8 mg, gélule…ATCN06DA04REGISTER NO.FR:63947710PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Galantamine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06DA04 (galantamine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Galantamine · ATC N06DA04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of galantamine costs, country by country.

Normalised to the WHO defined daily dose (16 mg), the median price runs from $1.59 in Italy to $4.69 in Switzerland — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Galantamine · price per daily dose (16 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.69
  • ES Spain$1.88
  • IT Italy$1.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BROMHYDRATE DE GALANTAMINE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
N06DA04
ATC class
Galantamine
Defined daily dose
16 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930237274
    plaquette(s) PVC polyéthylène PVDC aluminium de 28 gélule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for galantamine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Galantamine · interactions on record

237 records

  • 8 severe
  • 202 moderate
  • 25 info

Most severe, free to view

  • OzanimodL04AA38severe
  • SiponimodL04AA42severe
  • OzanimodL04AE02severe
  • SiponimodL04AE03severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Galantamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All galantamine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Galantamin Actavis, Galantamin Krka
  • Belgium · Reminyl
  • Bulgaria · Галантамин Дс, Галсия Sr
  • Germany · Galanaxiro, Galantamin 1 A Pharma
  • Denmark · Galantamin Krka, Galantamin Stada
  • Spain · Galantamina Aurovitas Spain, Galantamina Cinfa
  • Finland · Galantamin Krka, Galantamin Orion
  • United Kingdom (Northern Ireland) · Consion Xl, Gaalin
  • Greece · Aneprosil, Galantamine Pharmathen
  • Ireland · Galsya Sr
  • Iceland · Galantamin Stada
  • Italy · Galnora, Reminyl
  • Liechtenstein · Reminyl
  • Luxembourg · Reminyl, Reminyl (Emballage De Départ)
  • Latvia · Nivalin
  • Malta · Galantamine Syri Pharma
  • Netherlands · Bergal Sr, Galantamine Hydrobromide Aurobindo
  • Norway · Galantamin Krka, Reminyl
  • Poland · Nivalin
  • Portugal · Galantamina Azevedos, Galantamina Bluelife
  • Romania · Galsya, Reminyl
  • Sweden · Galantamin Actavis, Galantamin Krka
  • Slovenia · Galabar Sr, Galema Sr
  • Slovakia · Galantamin Viatris, Galsya Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c7e5d6c-5adc-406e-b738-ad0a460f3faf
GET /v1/drugs/3c7e5d6c-5adc-406e-b738-ad0a460f3faf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63947710",
  "date_amm": "2021-09-22",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "BROMHYDRATE DE GALANTAMINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about galantamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.